SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-115792
Filing Date
2023-11-08
Accepted
2023-11-08 17:01:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2329910-3_424b5.htm 424B5 470429
2 EX-FILING FEES tm2329910d4_ex-filingfees.htm EX-FILING FEES 32538
3 GRAPHIC lg_celldextherapeutics-4c.jpg GRAPHIC 16646
  Complete submission text file 0001104659-23-115792.txt   527250
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275300 | Film No.: 231389067
SIC: 2835 In Vitro & In Vivo Diagnostic Substances